Experimental glioblastoma therapy shows curative powers in mice models

Houston Methodist researchers found that mice harboring human glioblastoma tumours in their brains had greatly enhanced survival and weight gain when given a newly developed prodrug.

This mitochondrial-targeted prodrug - an inactive compound that cancer cells selectively metabolise to produce an active toxic drug - also greatly improves outcomes when coupled with standard therapies of radiation and/or